XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis – topic of research paper in Clinical medicine.
Dimitrios DOUFEXIS | General University Hospital of Larissa, Lárisa | Oncology – Hematology Clinic
Yiannis A. Retsos on Twitter: "Συζητήσαμε με τον @K_Hatzidakis, τον @tsakloglou και τις ΓΓ Α. Στρατινάκη & Π. Καρασιώτου, τις προκλήσεις του Q1 & τις ανησυχίες για το Q2. Αναστολές, Συν-εργασία &
Ioannis Doufexis - SPARES & LUBRICANTS OPERATOR - Minerva Marine Inc. | LinkedIn